You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Prochlorperazine edisylate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for prochlorperazine edisylate and what is the scope of patent protection?

Prochlorperazine edisylate is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Teva Parenteral, Viwit Pharm, Watson Labs, and Wyeth Ayerst, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for prochlorperazine edisylate. Sixteen suppliers are listed for this compound.

Summary for prochlorperazine edisylate
US Patents:0
Tradenames:3
Applicants:20
NDAs:28
Drug Master File Entries: 9
Finished Product Suppliers / Packagers: 16
Raw Ingredient (Bulk) Api Vendors: 35
Patent Applications: 513
What excipients (inactive ingredients) are in prochlorperazine edisylate?prochlorperazine edisylate excipients list
DailyMed Link:prochlorperazine edisylate at DailyMed
Pharmacology for prochlorperazine edisylate
Drug ClassPhenothiazine

US Patents and Regulatory Information for prochlorperazine edisylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089530-001 Jul 8, 1987 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sagent PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 040540-001 May 28, 2004 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 213630-001 Nov 22, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare PROCHLORPERAZINE prochlorperazine edisylate INJECTABLE;INJECTION 087759-001 Oct 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxosmithkline COMPAZINE prochlorperazine edisylate INJECTABLE;INJECTION 010742-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 088597-001 Oct 25, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 214107-001 Sep 22, 2021 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.